Role of Activators of Ferric sGC in Cardiovascular Disease

BMC Pharmacology
doi 10.1186/1471-2210-5-s1-s19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Role of Adipokines in Cardiovascular Disease

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2012English

AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease

Pharmaceutical Regulatory Affairs: Open Access
2014English

Role of Obstructive Sleep Apnea in Cardiovascular Disease

Current Opinion in Cardiology
Cardiovascular MedicineCardiology
2011English

The Role of Intestinal Microbiota in Cardiovascular Disease

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

The Role of the Kidney in Cardiovascular Disease

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Role of Aripiprazole in the Treatment of Cardiovascular Disease

Cardiology and Cardiovascular Medicine
2018English

The Advantageous Role of Annexin A1 in Cardiovascular Disease

Cell Adhesion and Migration
Molecular NeuroscienceCell BiologyCellular
2016English

Role of the Renin-Angiotensin System in Cardiovascular Disease

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2010English

The Role of Tetrahydrobiopterin in Inflammation and Cardiovascular Disease

Thrombosis and Haemostasis
Hematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy